March 10, 2017 11:10 AM ESTUpdated 11:57 AM

Gottlieb continues to be Trump's leading candidate for FDA; BeyondSpring completes unusual IPO

Shehla Shakoor

Managing Director

→ Scott Gottlieb is President Trump’s leading choice for FDA commissioner, Bloomberg now reports, citing “people” familiar with the matter. BioCentury had the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Gottlieb continues to be Trump's leading candidate for FDA; BeyondSpring completes unusual IPO

Shehla Shakoor

Managing Director

Sign up to read this article for free.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

FDA rejects Stealth's rare disease drug, but offers potential for accelerated approval

Updated: Trump administration halts more than $750M in funds for Moderna’s bird flu vaccine

PepGen ditches Duchenne programs after mid-stage fail, switches to previously halted muscle wasting therapy

A new dawn for psychedelics? Compass could be the first to find out

Exclusive: Movement disorder biotech Vima steps onto scene with $60M

From weeks to days: how Aizon Intelligent Agents transform pharma validation

Got­tlieb con­tin­ues to be Trump's lead­ing can­di­date for FDA; Be­yond­Spring com­pletes un­usu­al IPO

Managing Director

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Gottlieb continues to be Trump's leading candidate for FDA; BeyondSpring completes unusual IPO